| 3333 |
2256: Activation of gluten- and TG2-reactive B cells |
1931: Disruption of the intestinal barrier |
Aug 13, 2024 |
Apr 27, 2025 |
1 AOP
|
| 3336 |
2256: Activation of gluten- and TG2-reactive B cells |
272: Activation/Proliferation, T-cells |
Aug 13, 2024 |
Aug 13, 2024 |
None
|
| 3345 |
2256: Activation of gluten- and TG2-reactive B cells |
2260: Activation of gluten-reactive CD4+ T cells |
Sep 13, 2024 |
Sep 13, 2024 |
None
|
| 3342 |
2260: Activation of gluten-reactive CD4+ T cells |
2256: Activation of gluten- and TG2-reactive B cells |
Sep 13, 2024 |
Feb 27, 2025 |
1 AOP
|
| 3343 |
2260: Activation of gluten-reactive CD4+ T cells |
1931: Disruption of the intestinal barrier |
Sep 13, 2024 |
Sep 13, 2024 |
None
|
| 3344 |
2260: Activation of gluten-reactive CD4+ T cells |
2252: Formation of HLA-DQ2/8-gluten complexes |
Sep 13, 2024 |
Sep 13, 2024 |
None
|
| 3329 |
2253: Generation of gluten-reactive T cell receptors |
272: Activation/Proliferation, T-cells |
Aug 13, 2024 |
Aug 13, 2024 |
None
|
| 3339 |
2253: Generation of gluten-reactive T cell receptors |
2260: Activation of gluten-reactive CD4+ T cells |
Sep 13, 2024 |
Sep 13, 2024 |
None
|
| 3385 |
2253: Generation of gluten-reactive T cell receptors |
2275: Co-localization of gluten reactive adaptive T-cells with APC |
Nov 12, 2024 |
Apr 8, 2025 |
1 AOP
|
| 3142 |
1800: Reduced granulosa cell proliferation |
405: disrupted, ovarian cycle |
Mar 7, 2024 |
Mar 18, 2025 |
1 AOP
|
| 1926 |
1647: GSK3beta inactivation |
1648: β-catenin activation |
May 29, 2019 |
May 29, 2019 |
None
|
| 2485 |
1647: GSK3beta inactivation |
1902: Repression of Gbx2 expression |
Oct 3, 2021 |
Dec 12, 2021 |
1 AOP
|
| 2533 |
1954: Gut dysbiosis |
1931: Disruption of the intestinal barrier |
Dec 2, 2021 |
Dec 2, 2021 |
None
|
| 2544 |
1954: Gut dysbiosis |
1497: Recruitment of inflammatory cells |
Dec 15, 2021 |
Dec 15, 2021 |
None
|
| 3440 |
2295: HCN Channel Inhibition |
2296: Reduced Pacemaker Activity in SA Node |
Nov 24, 2024 |
Nov 24, 2024 |
1 AOP
|
| 2508 |
1535: Heart failure |
1948: Upregulation of ACE2 |
Oct 28, 2021 |
Oct 28, 2021 |
None
|
| 2514 |
1535: Heart failure |
1946: Altered mechanotransduction properties of pericytes |
Oct 28, 2021 |
Oct 28, 2021 |
None
|
| 2825 |
1535: Heart failure |
350: Increase, Mortality |
Jan 5, 2023 |
Jan 5, 2023 |
None
|
| 1546 |
1412: Helicobacter pylori infection |
1384: Increase, ammonium (NH4+) |
Jun 2, 2017 |
Jun 2, 2017 |
1 AOP
|
| 1166 |
1133: Hemostasis, Depletion from blood of fully functional carboxylated clotting factors |
1122: Under carboxylated clotting factors will not assemble on cell surfaces to form clot, Failur |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1514 |
1393: Hepatocytotoxicity |
1394: Sustained proliferation |
May 30, 2017 |
Jun 19, 2021 |
1 AOP
|
| 1517 |
1393: Hepatocytotoxicity |
1395: Liver Cancer |
May 30, 2017 |
May 1, 2020 |
1 AOP
|
| 2535 |
1957: hERG channel biogenesis interference |
1958: Direct hERG channel blockage |
Dec 13, 2021 |
Dec 13, 2021 |
None
|
| 2536 |
1957: hERG channel biogenesis interference |
1959: Induction of hERG trafficking defects |
Dec 13, 2021 |
Dec 13, 2021 |
None
|
| 2850 |
2099: hERG channel blockade |
2100: Inhibition of rapid delayed rectifying potassium current |
Jan 29, 2023 |
Jan 29, 2023 |
1 AOP
|